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ORIGINAL ARTICLEDirect blood culturing on solid medium outperforms an automated
continuously monitored broth-based blood culture system in terms of time
to identiﬁcation and susceptibility testingE. A. Idelevich, B. Grünastel, G. Peters and K. Becker
Institute of Medical Microbiology, University Hospital Münster, GermanyAbstractPathogen identiﬁcation and antimicrobial susceptibility testing (AST) should be available as soon as possible for patients with bloodstream
infections. We investigated whether a lysis-centrifugation (LC) blood culture (BC) method, combined with matrix-assisted laser
desorption ionization time-of-ﬂight mass spectrometry (MALDI-TOF MS) identiﬁcation and Vitek 2 AST, provides a time advantage in
comparison with the currently used automated broth-based BC system. Seven bacterial reference strains were added each to 10 mL
human blood in ﬁnal concentrations of 100, 10 and 1 CFU/mL. Inoculated blood was added to the Isolator 10 tube and centrifuged at
3000 g for 30 min, then 1.5 mL sediment was distributed onto ﬁve 150-mm agar plates. Growth was observed hourly and microcolonies
were subjected to MALDI-TOF MS and Vitek 2 as soon as possible. For comparison, seeded blood was introduced into an aerobic BC
bottle and incubated in the BACTEC 9240 automated BC system. For all species/concentration combinations except one, successful
identiﬁcation and Vitek 2 inoculation were achieved even before growth detection by BACTEC. The fastest identiﬁcation and inoculation
for AST were achieved with Escherichia coli in concentrations of 100 CFU/mL and 10 CFU/mL (after 7 h each, while BACTEC ﬂagged
respective samples positive after 9.5 h and 10 h). Use of the LC-BC method allows skipping of incubation in automated BC systems and,
used in combination with rapid diagnostics from microcolonies, provides a considerable advantage in time to result. This suggests that the
usefulness of direct BC on solid medium should be re-evaluated in the era of rapid microbiology.
New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases.
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E-mail: kbecker@uni-muenster.deIntroductionIt is well recognized that sepsis mortality can be considerably
lowered if adequate antimicrobial therapy is administered early,
ideally in the ﬁrst hour after onset of symptoms [1]. Obviously,
at this very early time point, the causative agent is unknown and
the therapy can only be chosen empirically. Nevertheless, rapidNew Microbes and New Infections © 2015 The Authors. Published by El
This is an open access artimicrobiological diagnostics still provide signiﬁcant beneﬁt for
patients by shortening the time to appropriate antimicrobial
treatment [2,3], reducing mortality [4] and length of hospital
stay [3]. Recently, the improvement of clinical outcomes due to
rapid diagnostics has been conﬁrmed using matrix-assisted laser
desorption ionization time-of-ﬂight mass spectrometry
(MALDI-TOF MS) -based identiﬁcation [5–9]. Considerable
advances have been achieved in rapid identiﬁcation applying
direct MALDI-TOF MS to positive blood cultures (BCs) [10] or
performing MALDI-TOF MS on a tiny biomass grown very
quickly (a few hours) on solid medium after sub-culturing from
positive BCs [11–14]. However, incubation of blood samples in
automated liquid medium BC systems remains a substantial
time-limiting factor. This approach, using continuousNew Microbe and New Infect 2016; 10: 19–24
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reference standard for detection of microorganisms in blood
for the last three decades [15,16]. Before the introduction of
these systems, lysis-centrifugation BC (LC-BC) method was
commonly used [17–19]. This method implements lysis of
blood cells in a whole blood sample and centrifugation of the
lysed blood, followed by the removal of supernatant and plating
of the sediment onto the solid media [20,21]. We hypothesized
that this solid-medium-based direct cultivation method, applied
in combination with MALDI-TOF MS may enable faster bacte-
rial identiﬁcation than automated BC systems. Furthermore,
this study aimed to investigate the use of the early available
colonies for antimicrobial susceptibility testing (AST).Materials and methodsBacterial strains and preparation of spiked blood
samples
Seven reference strains of different bacterial species—
Escherichia coli (ATCC 35218), Pseudomonas aeruginosa (ATCC
27853), Staphylococcus aureus (ATCC 29213), Staphylococcus
epidermidis (ATCC 12228), Enterococcus faecalis (ATCC 29212),
Streptococcus pneumoniae (ATCC 49619) and Haemophilus inﬂu-
enzae (NCTC 8468)—were cultured on Columbia blood agar
(chocolate agar for H. inﬂuenzae) for 24 h at 36°C. Suspensions
with a standardized turbidity of 0.5 McFarland were prepared in
0.85% saline solution (in a preliminary experiment, an expected
cell concentration of 0.5 McFarland standard suspension was
determined in triplicate for each strain by serial dilution and
colony count of plated suspensions). From 0.5 McFarland sus-
pensions, dilution series were prepared and individually calcu-
lated volumes (89–350 μL, based on the results of the
preliminary experiment) of the appropriate dilution of each
strain were added to 10 mL human whole blood to produce ﬁnal
concentrations of 100, 10 and 1 CFU/mL in blood. The real ﬁnal
inoculum size of each suspension used was veriﬁed by plating and
incubating on tryptic soy agar, Columbia blood agar (for Strep-
tococcus pneumoniae) or chocolate agar (for H. inﬂuenzae).
Human whole blood was obtained from healthy volunteer
donors not receiving any systemic medication. The volunteers
provided written informed consent before blood donation.
Blood was collected in sterile bags (Leukotrap® WB, Pall
Medical, Port Washington, NY, USA).
Sample processing and incubation
Ten millilitres of inoculated blood was aseptically introduced
into an Isolator 10 tube (Wampole Laboratories, Princeton, NJ,
USA) containing saponin for blood cell lysis and sodium poly-
anethol sulphonate as an anticoagulant by piercing the rubberNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceseptum with a sterile needle. Immediately after adding the
spiked blood sample, tubes were gently inverted several times
and centrifuged at 3000 g for 30 min. After removal of super-
natant, 1.5 mL sediment was vortexed and evenly distributed
onto ﬁve pre-warmed 150-mm Columbia blood agar plates
(chocolate agar for H. inﬂuenzae). All plates were incubated at
36°C in air with 5% CO2. Growth was observed hourly and
microcolonies were subjected to MALDI-TOF MS for identiﬁ-
cation and to Vitek 2 for AST as soon as it was deemed
possible. Incubation of agar plates was continued up to 24 h and
both identiﬁcation and AST were performed from mature
colonies as control.
For comparison, seeded blood was inoculated into an aer-
obic blood culture bottle (BACTEC™ Plus Aerobic/F; BD Di-
agnostics, Heidelberg, Germany) and incubated in an automated
BC system (BACTEC™ 9240; BD Diagnostics). Time to posi-
tivity (i.e. growth detection) was automatically recorded.
All experiments were performed in triplicate on different
days and median values were calculated for analysis.
MALDI-TOF MS identiﬁcation
MALDI-TOF MS using intact cell procedure [11] was per-
formed at the time point at which microcolonies became visible
and it was considered after visual inspection that the colony
material could be sufﬁcient for investigation. Spectra were ac-
quired using the Microﬂex LT system (Bruker Daltonics, Bre-
men, Germany) and analysed by MALDI BIOTYPER 3.1 (Bruker
Daltonics) software. MALDI-TOF MS analysis was performed in
triplicate, with tests performed simultaneously on the same
target slide. Criteria for successful identiﬁcation were fulﬁlled if
the score of at least one from three spots was 2.0 (high
conﬁdence identiﬁcation); however, the time point of
achievement of low conﬁdence identiﬁcation (score 1.7) as
well as achievement of the modiﬁed threshold (score 1.5 and
ﬁrst three identical propositions) were also recorded. The
experiment was stopped when intact cell identiﬁcation was
successful. If not, intact cell MALDI-TOF MS was repeated
hourly until successful identiﬁcation (score 2.0). Also, in the
case of failed intact cell identiﬁcation, it was attempted to in-
crease the score at the same time point by (a) giving additional
manual laser shots on the same spots, (b) repeating MALDI-
TOF MS analysis using the short on-plate extraction proce-
dure [22], and (c) giving additional manual shots if MALDI-TOF
MS with on-plate extraction also failed. For control, intact cell
MALDI-TOF MS was also performed at 24 h.
Antimicrobial susceptibility testing
During the hourly inspection of plates, the ﬁrst time point was
determined at which the growth appeared sufﬁcient for prep-
aration of 0.5 McFarland suspension to be used for AST byEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 10, 19–24
nses/by-nc-nd/4.0/)
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N214 (for Escherichia coli), N248 (for P. aeruginosa), P632 (for
S. aureus and S. epidermidis), P586 (for E. faecalis) and P576 (for
Streptococcus pneumoniae) cards. Similar to routine diagnostics,
no Vitek 2 AST was performed for H. inﬂuenzae. Unlike the
manufacturer’s recommendation to prepare 0.5 McFarland
suspensions in 3.0 mL saline [23], we used a reduced volume of
approximately 1.5 mL, because this reduces the amount of
microcolonial biomass needed, which is enough for Vitek 2 AST
if no simultaneous Vitek 2 identiﬁcation is performed. The
median AST results for each species/concentration combination
were compared with the corresponding results produced by
the testing of mature 24-h cultures.ResultsMedian time to identiﬁcation using different conﬁdence
thresholds and median time needed for AST (cultivation time
until Vitek 2 inoculation, duration of Vitek 2 testing and total
time to result) after the processing by the direct LC-BC
method are demonstrated in Table 1. For comparison, me-
dian time until BACTEC positivity signal (growth detection) is
also shown (Table 1).
In 20 of the 21 species/concentration combinations, high
conﬁdence species identiﬁcation (score 2.0) after LC-BC wasTABLE 1. Median time to MALDI-TOF MS identiﬁcation result an
testing (AST) after the processing by a lysis-centrifugation dire
BACTEC positivity signal
Organism
Concentration
(CFU/mL)
Time to MALDI-TOF MS identiﬁcatio
direct blood culture method (h)
High
conﬁdence
(score ‡2.0)
Low
conﬁdence
(score ‡1.7)
Modiﬁe
(score ‡
identica
Escherichia coli 100 7 7 7
10 7 7 7
1 8 8 8
Pseudomonas aeruginosa 100 11 11 (10b) 11 (10b)
10 11 11 11
1 12 12 12
Staphylococcus aureus 100 8 8 8
10 8 8 8
1 10 (9a) 9 9
Staphylococcus epidermidis 100 14 (13a) 13 13
10 15 (14a) 15 (14a) 14
1 15 15 15
Enterococcus faecalis 100 9 (8a) 8 8
10 9 9 9
1 10 10 10
Streptococcus pneumoniae 100 9 8 8
10 9 9 9
1 12 12 12
Haemophilus inﬂuenzae 100 11 11 11
10 11 11 11
1 11 11 11
aTime to identiﬁcation was reduced by on-plate extraction.
bTime to identiﬁcation was reduced by on-plate extraction followed by additional shots.
cNo Vitek 2 antimicrobial susceptibility testing is routinely performed for H. inﬂuenzae.
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This is an open access artiachieved even before BACTEC had detected growth in the
corresponding samples (the time point at which usually only
Gram stain would be possible with automated BC systems).
The only exception was S. epidermidis at a concentration of
100 CFU/mL, which was identiﬁed at 14 h by LC-BC, but
BACTEC ﬂagged the bottle positive after 13.9 h. Notably,
MALDI-TOF MS identiﬁcation after LC-BC was achieved after
13 h (i.e. earlier than the BACTEC positive signal) in this strain
at this concentration when a score threshold of 1.7 or a score
2.0 with on-plate extraction was used (Table 1). On average,
for all species at all bacterial concentration levels, high conﬁ-
dence species identiﬁcation (score 2.0) was achieved by the
intact cell protocol (without extraction) 3.3 h earlier than
BACTEC required for growth detection in the corresponding
samples. With a score 2.0 and use of on-plate extraction for
some samples, this difference reached 3.5 h. With a low con-
ﬁdence identiﬁcation threshold of 1.7, the average difference
amounted to 3.5 h and 3.6 h, respectively, when extraction or
extraction with additional manual shots was used for some
samples. With the modiﬁed threshold (score 1.5 and three
identical propositions), the average difference to BACTEC
positivity time was 3.6 h.
Similarly, Vitek 2 inoculation was possible before the BAC-
TEC positive signal for corresponding samples in 17 of 18
species/concentration combinations. The exception was again
S. epidermidis at a concentration of 100 CFU/mL. Vitek 2 testingd median time needed for Vitek 2 antimicrobial susceptibility
ct blood culture method, in comparison with the time to
n after Time to Vitek 2 AST after direct
blood culture method (h)
Time to
BACTEC
positivity
signal, h
d threshold
1.5 and three
l propositions)
Time until
Vitek 2
inoculation
Duration of
Vitek 2 AST
Total time to
Vitek 2 result
7 7.8 14.8 9.5
7 7.8 14.8 10.0
8 7.8 15.8 11.0
11 12.3 23.3 13.5
12 13 25.0 15.5
13 14.8 27.8 17.2
8 10.8 18.8 10.7
8 11.3 19.3 12.7
9 10.8 19.8 14.0
14 11.8 25.8 13.9
14 14 28.0 16.1
17 13 30.0 17.8
8 11.5 19.5 10.7
9 11.8 20.8 11.9
10 12 22.0 13.0
9 13.8 22.8 10.2
10 13.8 23.8 11.5
12 10.3 22.3 12.4
—c — — 16.3
— — — 18.6
— — — 20.0
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positivity signal. On average for all bacterial concentrations of
six species, Vitek 2 AST from colonies cultivated after the LC-
BC procedure was started 2.5 h earlier than BACTEC detected
bacterial growth in the comparison samples. A complete AST
report was ready on average 9.0 h after the BACTEC positivity
signal for corresponding samples. An AST proﬁle was generated
in all tests without any technical errors or abort runs. For all
species/concentration/antibiotic combinations but one, essen-
tial agreement (MIC result within plus or minus one of doubling
dilution step [24]) was achieved, compared with the testing of
standard 24-h cultures. Only in S. epidermidis at a concentration
of 10 CFU/mL, was the median penicillin MIC for short culture
two dilutions lower than the value from the 24-h culture.
Categorical agreement (correct categorization as susceptible,
intermediate or resistant [24]) was achieved for all species/
concentration combinations.DiscussionOur study demonstrated considerable time saving by direct
blood culture on solid medium using the LC-BC method
combined with MALDI-TOF MS identiﬁcation and Vitek 2 AST
from the microcolonies grown. In almost all cases, species
identiﬁcation and inoculation of the AST system was possible
even before the BACTEC positive signal for corresponding
samples. In most cases, successful identiﬁcation was achieved
when microcolonies were visually considered sufﬁcient for
identiﬁcation. Application of extraction, additional shots, or
lowered thresholds further reduced the time to identiﬁcation in
only a few cases. In some cases, differences between time to
successful identiﬁcation from solid medium and time to growth
detection by BACTEC were particularly pronounced. For
instance, after 11 h, H. inﬂuenzae (1 CFU/mL) was already
identiﬁed by MALDI-TOF MS subsequent to LC-BC. In
contrast, it took a further 9 h until BACTEC detected growth in
the corresponding bottle (Table 1). Other examples are dif-
ferences of 5.2 h and 4.7 h for P. aeruginosa (1 CFU/mL) and
S. aureus (10 CFU/mL) samples, respectively (Table 1).
The time advantage of LC-BC in comparison with BACTEC
was more pronounced in samples with lower bacterial con-
centrations (Table 1). This trend was observed for both time
until identiﬁcation and time until Vitek 2 inoculation. Rapid di-
agnostics of ‘low-CFU’ samples appear particularly important
because most bacteraemias represent low inoculum infections
[25]. It additionally demonstrates the feasibility of early use of
small amounts of microcolonies for diagnostics and high recov-
ery rates with LC-BC. The recovery rate after 24 h of growth
was 92–96% in preliminary experiments (data not shown).New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceUse of the LC-BC method allows the incubation in auto-
mated BC systems to be skipped by direct blood culturing,
which provides a time advantage. Here, we did not sub-culture
positive BC bottles to measure the incubation times necessary
for identiﬁcation and inoculation for AST in the comparison
group. However, these times have been thoroughly investigated
in our previous studies [11,26] and by other authors [12–14].
Both time to identiﬁcation and time to Vitek 2 inoculation were
longer in the present study than was demonstrated for very
brieﬂy incubated cultures on solid medium after sub-cultivation
from positive BC bottles [11]. This is most probably a result of
the differences in the inoculum size being introduced onto the
agar. In incubated BC bottles, high inocula are reached, which
after sub-culturing rapidly result in visible bacterial growth,
described as lawn, haze, or veil, after several hours [11–14]. In
contrast, individual microcolonies are observed as a result of
the direct cultivation on agar after LC-BC because of a low
(real) inoculum size. These separate microcolonies obviously
need more time than bacterial lawn until they become visible
for the investigator and can be used for analysis. However, the
fact that species identiﬁcation and inoculation in the AST sys-
tem were possible even before the BACTEC positivity signal in
almost all cases, shows that it is still advantageous to start in-
cubation directly on solid medium and not in liquid medium. In
the latter case, detection of growth by the automated BC
system is only a starting point for sub-culture onto agar and
subsequent incubation. In this study, AST from microcolonies
directly cultured on solid medium generated a ﬁnal result on
average 9.0 h after the BACTEC positivity signal for corre-
sponding samples processed in this automated system. Ac-
cording to a previous study, the total time from positive BC
sub-culture (at positivity signal) to AST result was 33–34 h
with a standard procedure using the automated BC system [26].
It included standard 24-h cultivation time until Vitek 2 inocu-
lation and duration of Vitek 2 AST. Notably, the total time to
result is considerably shorter if the method of brieﬂy incubated
solid medium cultures is used for positive BCs [26,27].
With the advent of automated BC incubators, the use of an
Isolator system has been largely abandoned. Comparative studies
demonstrated earlier detection of microbial growth or reduced
processing time by the automated continuous monitoring sys-
tems [17,18,28,29]. However, even back then, some authors
recognized that (a) detection with the Isolator could have been
earlier if one had observed the plates more frequently [17,18],
and (b) the time to availability of isolated colonies is more
important than the time to detection [19], because at the latter
time point only Gram stain is possible with automated BC sys-
tems, and the broth has to be sub-cultured on solid medium to
gain colonies for identiﬁcation and AST. In contrast, the Isolator
directly delivers colonies on solid medium, which areEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 10, 19–24
nses/by-nc-nd/4.0/)
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for faster diagnostics. Further advantages of direct blood
culturing on solid medium include that: (a) quantiﬁcation of
bacterial load is possible; (b) Gram staining can be omitted
because species identiﬁcation is done by MALDI-TOF MS even
more easily and quickly once the colony has become visible; (c)
false-positive signals of automated systems (in the absence of any
microbial growth) are avoided; and (d) release and better
detection of intracellular bacteria due to blood lysis (lysis re-
agents are also included in some media for automated systems).
We do not generally advocate the switch from automated
BC systems to the Isolator system because of existing technical
and logistical drawbacks. The most reported shortcomings of
an LC-BC approach are the increased workload in the labo-
ratory (the need for centrifugation and manual distribution of
sediment) and the possibility of contamination [17,18,28]. The
laboratories using this system should establish the optimal
specimen processing and feasible intervals for observation of
agar plates within the laboratory’s operating hours. We believe
that technical improvements of direct blood culturing on solid
media such as easier blood processing (feasible at a patient’s
bed), exploitation of storage and transport times as well as
contamination-free operation (E.A. Idelevich and K. Becker,
pending patent application) will make this method most suitable
for the modern diagnosis of bloodstream infections. Compati-
bility with ‘intelligent’ incubators will further accelerate and
optimize diagnosis through early automatic growth detection by
imaging technology as well as automatic transfer of micro-
colonies to the identiﬁcation and AST systems.
In conclusion, direct blood cultivation on solid medium en-
ables much earlier identiﬁcation and AST than a liquid-based
automated BC system. This ﬁnding is striking and suggests
that the usefulness of direct blood cultivation on solid medium
should be re-evaluated in the era of rapid microbiology.AcknowledgementsThis work was presented in part at the 54th Interscience
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